| Development and Exploration of the Effectiveness and Feasbility of a Digital Intervention for Type 2 Diabetes Mellitus (NCT05364476) | EVYD Technology | 2022-04-11 |
| TARDIS - Photo Elicitation and Intervention (NCT06972251) | VA Office of Research and Development | 2022-03-08 |
| Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy (NCT04667143) | Jiangsu HengRui Medicine Co., Ltd. | 2021-01-01 |
| ´Sit Less, Move More' at Work: mHealth Intervention on Office Employees With Diabetes Type 2. (NCT04092738) | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 2019-03-04 |
| Fenofibrate in Type 2 Diabetes (NCT03829514) | Medical University of South Carolina | 2019-02-04 |
| A Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT03596177) | MedImmune LLC | 2018-09-26 |
| Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric Air (NCT03138746) | University of Adelaide | 2018-08-13 |
| Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 (NCT03616392) | Chong Kun Dang Pharmaceutical | 2018-07-25 |
| GOLO Open-Label Pilot 1 (NCT03478202) | Golo | 2017-08-01 |
| Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes (NCT03014011) | Bispebjerg Hospital | 2017-06-13 |
| Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema (NCT02985242) | Hannover Medical School | 2017-06-12 |
| Episodic to Real-Time Care in Diabetes Self-Management (NCT03012074) | Duke University | 2017-03-02 |
| Measuring Patient Engagement in Diabetes Care (NCT02988427) | Northwestern University | 2016-12-01 |
| Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes (NCT02946632) | Korea University Anam Hospital | 2016-12-01 |
| Impact of Periodontal Therapy on Patients With Diabetes (NCT04830969) | State University of New York at Buffalo | 2016-11-08 |
| CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) (NCT02824874) | Chong Kun Dang Pharmaceutical | 2016-04-01 |
| A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers (NCT02685774) | Chong Kun Dang Pharmaceutical | 2016-02-01 |
| Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus (NCT03112382) | Cairo University | 2015-11-01 |
| Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers (NCT02648854) | Chong Kun Dang Pharmaceutical | 2015-10-01 |
| A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers (NCT02627027) | Chong Kun Dang Pharmaceutical | 2015-08-01 |
| A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers (NCT02565368) | Chong Kun Dang Pharmaceutical | 2015-07-01 |
| Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood (NCT02650206) | Stanford University | 2015-01-01 |
| Impact of Sleep and Meal Timing on Food Intake Regulation (NCT02347020) | Columbia University | 2014-10-01 |
| The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes Patient (NCT02261545) | Tehran University of Medical Sciences | 2014-09-01 |
| Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills (NCT02128854) | Medical University of South Carolina | 2014-08-14 |
| Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus (NCT02175121) | Pfizer | 2014-08-01 |
| Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II (NCT02144948) | GWT-TUD GmbH | 2014-08-01 |
| Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar (NCT02175537) | Microclinic International | 2014-06-01 |
| Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes (NCT01453751) | Ageless Regenerative Institute | 2014-03-01 |
| Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus (NCT02036372) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2014-01-01 |
| Detection of Diffuse Scar in Patients With Diabetes (NCT01794091) | Brigham and Women's Hospital | 2013-08-01 |
| A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use (NCT01669473) | Northwestern University | 2013-06-01 |
| Technology Intensified Diabetes Education Study in African Americans (NCT02088658) | State University of New York at Buffalo | 2013-05-01 |
| Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4 (NCT01775059) | Medtronic Diabetes R&D Denmark | 2013-03-01 |
| EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus (NCT03258840) | Tehran University of Medical Sciences | 2013-01-01 |
| VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel (NCT01684813) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2012-10-01 |
| Bioequivalence Study for Acarbose / Metformin FDC (NCT01728740) | Bayer | 2012-09-01 |
| Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive Measurements (NCT02028091) | Medical University of Vienna | 2012-09-01 |
| E-health Care Process Support for Diabetes Type II Patients (NCT01566981) | University of Primorska | 2012-03-01 |
| Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics (NCT01654120) | Mountain Diabetes and Endocrine Center | 2011-12-01 |
| Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy (NCT01565096) | ikfe-CRO GmbH | 2011-11-01 |
| Micro-Clinic Obesity and Metabolic Risk Prevention Program (NCT01651065) | Microclinic International | 2011-06-01 |
| A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers. (NCT01301092) | Eli Lilly and Company | 2011-02-01 |
| Single Dose Escalation Study of PF-05190457 in Healthy Volunteers (NCT01247896) | Pfizer | 2010-12-01 |
| The Effects of a Regenerative Mitochondrial Medication on Physiological Parameters in Case of Diabetes Mellitus Type II (NCT01197092) | Center for Integrative Medicine, Germany | 2010-11-01 |
| Effect of Calcium Polycarbophil on Type II Diabetes Mellitus Control: a Randomized Double-blind Study (NCT01252524) | East Carolina University | 2010-10-01 |
| Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus (NCT01194258) | Halozyme Therapeutics | 2010-08-01 |
| Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control (NCT01066039) | Merck KGaA, Darmstadt, Germany | 2010-04-01 |
| Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. (NCT01281098) | Association for Innovation and Biomedical Research on Light and Image | 2010-03-01 |
| Mechanisms of Glycemic Improvement After Gastrointestinal Surgery (NCT01025999) | University of Washington | 2010-01-01 |
| Multicenter Research Study to Build a Repository to Study Chronic Diseases in Indiana (NCT01386801) | Fairbanks Institute | 2009-12-01 |
| Predictors of Future Type 2 Diabetes Mellitus in Circassians Minority in Israel (NCT01311401) | Ziv Hospital | 2009-10-01 |
| Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone (NCT00970424) | Forest Laboratories | 2009-08-01 |
| Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin (NCT00947557) | Forest Laboratories | 2009-07-01 |
| Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients (NCT00649909) | Hadassah Medical Organization | 2008-11-01 |
| Telephone Delivered Behavioral Skills Intervention for Blacks With T2DM (NCT00929838) | State University of New York at Buffalo | 2008-08-01 |
| Jordan Diabetes Microclinic Project (NCT01596244) | Microclinic International | 2008-04-01 |
| Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders (NCT00660790) | Medical University of Graz | 2008-04-01 |
| An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes (NCT00642278) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-04-01 |
| Diabetes Mellitus Type II and Tissue Oxygenation (NCT00554697) | The Cleveland Clinic | 2007-11-01 |
| Study of INT-747 in Patients With Diabetes and Presumed NAFLD (NCT00501592) | Intercept Pharmaceuticals | 2007-07-01 |
| Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy (NCT00237952) | Chang Gung Memorial Hospital | 2005-08-01 |
| The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM) (NCT00131287) | ECbiotech Taiwan | 2005-07-01 |
| LANN-study: Lantus, Amaryl, Novorapid, Novomix Study (NCT00151697) | Rijnstate Hospital | 2005-05-01 |
| Rosiglitazone to Reverse Metabolic Defects in Diabetes (NCT00094796) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-10-20 |
| Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED) (NCT00086515) | Merck Sharp & Dohme LLC | 2004-06-30 |
| Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) (NCT00081328) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-05-01 |
| A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus (NCT00952445) | InteKrin Therapeutics, Inc. | 2003-12-01 |
| Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM (NCT00577590) | Washington University School of Medicine | 2003-10-01 |
| Dyslipidemia in Type 2 Diabetes (0767-034) (NCT00547274) | Merck Sharp & Dohme LLC | 2003-07-01 |
| A Study of MK0431 in Patients With Type 2 Diabetes (0431-010) (NCT00482079) | Merck Sharp & Dohme LLC | 2003-05-13 |
| 20 Week Bridging Study in Type II DM (NCT00563225) | Sanofi | 2002-10-01 |
| Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients (NCT00189774) | Astellas Pharma Inc | |